Inventor · disambiguated record
Jean-Charles Soria
Also filed as: SORIA JEAN · SORIA JEAN-CHARLES
6 granted patents·9 pending applications·15 citations·filing 2007–2023
75Inventor score
Top patents by PatentIndex Score
15 records- 0188US12224043B2Methods for determining treatment for cancer patientsMEDIMMUNE LLC·Filed 2023·Granted Feb 11, 2025·1 cites·20 claims
- 0287US11798653B2Methods for determining treatment for cancer patientsMEDIMMUNE LLC·Filed 2019·Granted Oct 24, 2023·5 cites·11 claims
- 0382US10555951B2Targeted treatment of leiomyosarcomaLILLY CO ELI·Filed 2016·Granted Feb 11, 2020·6 cites·9 claims
- 0462US10095829B2Computer implemented methods of treating lung cancerLAZAR VLADIMIR·Filed 2010·Granted Oct 9, 2018·3 cites·32 claims
- 0555US2010136137A1Therapeutic combination of a panher/vegfr2 kinase inhibitor and a platinum compoundBRISTOL MEYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 0645US2019005190A1Method for predicting efficacy of drugs in a patientWORLDWIDE INNOVATIVE NETWORK·Filed 2018·Application pending·0 cites
- 0742US10617717B2Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination therapyEXPRESSION PATHOLOGY INC·Filed 2017·Granted Apr 14, 2020·0 cites·10 claims
- 0842US2019353658A1Improved Methods Of Treating Lung Cancer Using Multiplex Proteomic AnalysisEXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
- 0941US2009215090A1Ercc1 expression in predicting response for cancer chemotherapyFOURET PIERRE·Filed 2007·Application pending·0 cites
- 1040US2015133323A1Method for characterizing circulating tumor cells, and use thereof in diagnosisROUSSY INST GUSTAVE·Filed 2012·Application pending·0 cites
- 1138US9702875B2Expression of isoform 202 of ERCC1 for predicting response to cancer chemotherapyOLAUSSEN KEN·Filed 2014·Granted Jul 11, 2017·0 cites·9 claims
- 1234US2012004136A1Msh2 and adjuvant cisplatin-based chemotherapy in non-small-cell lung cancerFOURET PIERRE·Filed 2010·Application pending·0 cites
- 1332US2013281313A1Prognostic and/or predictive biomarkers and biological applications thereofGALLUZZI LORENZO·Filed 2011·Application pending·0 cites
- 1431US2012277110A1Parp and adjuvant cisplatin-based chemotherapy in non-small-cell lung cancerANDRE FABRICE·Filed 2010·Application pending·0 cites
- 1531US2014120543A1Expression of isoform 202 of ercc1 for predicting response to cancer chemotherapyOLAUSSEN KEN·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →